It’s clear that the majority of university students experience high levels of stress during their degree. But a few simple stress reduction techniques and small lifestyle changes can help with this. So if you’re a student, or heading off to university for the first time, here’s what you need to know about managing stress.

While it is quite natural to experience uncertainty as uncomfortable, for some it is seemingly unbearable. Psychologists have even suggested that finding it difficult to cope with the experience of not knowing (also known as intolerance of uncertainty) could seriously affect our mental health – occurring alongside a number of conditions. But does it play any part in causing them?

Not long after the series debuted, Hong and his colleagues at PES noticed a disturbing trend: the number of teens coming in with suicide-related concerns was spiking. “We’re talking maybe 30% to 50% more than we would have expected."

You probably experience worry, stress or anxiety at least once on any given day. Nearly 40 million people in the U.S. suffer from an anxiety disorder, according to the Anxiety and Depression Association of America. Three out of four Americans reported feeling stressed in the last month, a 2017 study found. But in one of these moments, if asked which you were experiencing — worry, stress or anxiety — would you know the difference?

Agomelatine safely reduces symptoms of depression in children and adolescents with major depressive disorder (MDD), according to a study presented at the Virtual 33rd European College of Neuropsychopharmacology Congress (ECNP).

The use of SSRIs for the treatment of depression and anxiety in young people is increasing. However, the effects of
SSRIs in adolescence, a time when there are substantial changes in neural, cognitive, and social functioning, are not
well understood. Here, we review evidence from clinical trials about the benefits and risks of SSRIs in young people
and consider their mechanisms of action, as shown through human experimental work and animal models. We
emphasise key outstanding questions about the effects of SSRIs in youth, identified through gaps in the literature
and in consultation with young people with lived experience. It is crucial to characterise the mechanisms underpinning
risks and benefits of SSRIs in this age group to progress the field, and to narrow the chasm between the widespread
use of SSRIs in youth and the science on which this use is based.

https://hbr.org/2016/11/3-ways-to-better-understand-your-emotions?utm_campaign=meetedgar&utm_medium=social&utm_source=meetedgar.com

Up to 30% of people with depression don’t respond to treatment with antidepressants. This may be down to differences in biology between patients and the fact that it often takes a long time to respond to the drugs – with some people giving up after a while. So there is an urgent need to expand the repertoire of drugs available to people with depression.
In recent years, attention has turned to psychedelics such as psilocybin, the active compound in “magic mushrooms”. Despite a number of clinical trials showing that psilocybin can rapidly treat depression, including for cancer-related anxiety and depression, little is known about how psilocybin actually works to relieve depression in the brain.
Now two recent studies, published in The New England Journal of Medicine and Nature Medicine, have shed some light on this mysterious process.